1. Home
  2. DRIO

as of 02-23-2026 10:41am EST

$11.28
+$0.00
+0.04%
Stocks Health Care Medical/Dental Instruments Nasdaq

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Founded: 2011 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 84.1M IPO Year: 2013
Target Price: $50.00 AVG Volume (30 days): 19.1K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 9.05 EPS Growth: -68.39
52 Week Low/High: $0.38 - $17.74 Next Earning Date: 01-01-0001
Revenue: $7,394,000 Revenue Growth: 43.02%
Revenue Growth (this year): -16.35% Revenue Growth (next year): 16.15%
P/E Ratio: 1.25 Index: N/A
Free Cash Flow: -38700000.0 FCF Growth: N/A

Share on Social Networks: